跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,498 条关于
“MainlyAI AB”
全部
1,498
临床试验
262
药物
372
机构
499
资讯
365
去年
Diamyd Medical Advances Towards Potential Market Approval for Diamyd® in Type 1 Diabetes
去年
Diamyd Medical's DIAGNODE-3 Trial Reaches Recruitment Milestone, Eyes Accelerated Approval
去年
Diamyd Medical Warrants Expire as Phase 3 Trial Readout Nears
Diamyd Medical Receives U.S. FDA Fast Track Designation for Diamyd®
去年
South Korea Grants Diamyd Medical Patent for Insulin Antigen Therapy in Autoimmune Diabetes
去年
Diamyd Medical Partners with INNODIA to Boost Type 1 Diabetes Trial
去年
Diamyd Medical Secures Key Patents for Precision Medicine Approach to Type 1 Diabetes Treatment
8个月前
Diamyd Medical's Type 1 Diabetes Immunotherapy Receives Global Non-Proprietary Name "Retogatein"
去年
Diamyd Medical Partners with INNODIA to Boost Type 1 Diabetes Trial
去年
Diamyd Medical Secures Additional Funding for Phase III Type 1 Diabetes Trial with Fast Track Designation
第 1 页,共 37 页
上一页
下一页